Farallon Capital Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-9,300,000
| Closed | -$1.65B | – | 134 |
|
|
2020
Q1 | $1.65B | Buy |
9,300,000
+1,310,000
| +16% | +$232M | 14.14% | 1 |
|
|
2019
Q4 | $1.53B | Buy |
7,990,000
+1,755,000
| +28% | +$336M | 10.31% | 1 |
|
|
2019
Q3 | $1.05B | Buy |
6,235,000
+5,235,000
| +524% | +$881M | 7.92% | 2 |
|
|
2019
Q2 | $167M | Buy |
+1,000,000
| New | +$167M | 1.09% | 26 |
|
|
2017
Q3 | – | Sell |
-227,500
| Closed | -$55.3M | – | 97 |
|
|
2017
Q2 | $55.3M | Sell |
227,500
-420,000
| -65% | -$102M | 0.57% | 35 |
|
|
2017
Q1 | $155M | Sell |
647,500
-307,500
| -32% | -$73.5M | 1.7% | 20 |
|
|
2016
Q4 | $201M | Sell |
955,000
-45,000
| -5% | -$9.45M | 2.31% | 11 |
|
|
2016
Q3 | $230M | Buy |
1,000,000
+349,600
| +54% | +$80.5M | 3.37% | 5 |
|
|
2016
Q2 | $150M | Sell |
650,400
-512,100
| -44% | -$118M | 2.07% | 12 |
|
|
2016
Q1 | $312M | Sell |
1,162,500
-112,500
| -9% | -$30.2M | 2.98% | 6 |
|
|
2015
Q4 | $398M | Buy |
1,275,000
+380,589
| +43% | +$119M | 3.55% | 4 |
|
|
2015
Q3 | $243M | Sell |
894,411
-24,873
| -3% | -$6.76M | 3.21% | 4 |
|
|
2015
Q2 | $279M | Sell |
919,284
-66,000
| -7% | -$20M | 3.75% | 6 |
|
|
2015
Q1 | $293M | Buy |
985,284
+919,914
| +1,407% | +$274M | 4.28% | 4 |
|
|
2014
Q4 | $16.8M | Buy |
+65,370
| New | +$16.8M | 0.23% | 55 |
|
|
2014
Q1 | – | Sell |
-657,000
| Closed | -$110M | – | 104 |
|
|
2013
Q4 | $110M | Buy |
+657,000
| New | +$110M | 2.29% | 18 |
|